APA (7th ed.) Citation

Rigler, M., Praprotnik, M., Aldeco, M., Lepej, D., Zver, A., Rodman Berlot, J., . . . Krivec, U. (2024). P350 Dual x-ray absorptiometry body composition assessment in children and adolescents with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor. Journal of Cystic Fibrosis, 23, S175. https://doi.org/10.1016/S1569-1993(24)00646-5

Chicago Style (17th ed.) Citation

Rigler, M., et al. "P350 Dual X-ray Absorptiometry Body Composition Assessment in Children and Adolescents with Cystic Fibrosis Treated with Elexacaftor/tezacaftor/ivacaftor." Journal of Cystic Fibrosis 23 (2024): S175. https://doi.org/10.1016/S1569-1993(24)00646-5.

MLA (9th ed.) Citation

Rigler, M., et al. "P350 Dual X-ray Absorptiometry Body Composition Assessment in Children and Adolescents with Cystic Fibrosis Treated with Elexacaftor/tezacaftor/ivacaftor." Journal of Cystic Fibrosis, vol. 23, 2024, p. S175, https://doi.org/10.1016/S1569-1993(24)00646-5.